Liver transplantation recipients with nonalcoholic steatohepatitis have lower risk hepatocellular carcinoma
from Liver Transplantation
Liver transplantation (LT) is a well-established treatment for hepatocellular carcinoma (HCC) in carefully selected patients. Risk factors for tumors with poor prognostic features on explant have not been well described in a national cohort. We performed a retrospective cohort study of adult LT recipients with HCC transplanted from April 8, 2012 (when explant pathology in United Network for Organ Sharing [UNOS] became available) until Sept. 30, 2014.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063